Evidence map›Paper›PMID 32927238›Full record

ArticleBreast (Edinburgh, Scotland)2020

A case-control study of the joint effect of reproductive factors and radiation treatment for first breast cancer and risk of contralateral breast cancer in the WECARE study.

Jennifer D Brooks, John D Boice, Roy E Shore, Anne S Reiner, Susan A Smith, Leslie Bernstein, Julia A Knight, Charles F Lynch, Esther M John, Kathleen E Malone and 8 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Breast (Edinburgh, Scotland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.3field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 13 institutions in 4 countries.

Jennifer D BrooksUniversity of Toronto, Dalla Lana School of Public Health Sciences, Toronto, Canada. Electronic address: jennifer.brooks@utoronto.ca.
John D BoiceVanderbilt University Medical Center and the Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
Roy E ShoreNew York University School of Medicine, New York, NY, USA.
Anne S ReinerMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Susan A SmithThe University of Texas M.D. Anderson Cancer Centre, Houston, TX, USA.
Leslie BernsteinBeckman Research Institute, City of Hope National Medical Centre, Duarte, CA, USA.
Julia A KnightUniversity of Toronto, Dalla Lana School of Public Health Sciences, Toronto, Canada; Lunenfeld-Tanenbaum Research Institute, Sinai Health System, Toronto, Canada.
Charles F LynchUniversity of Iowa, Iowa City, IA, USA.
Esther M JohnDepartment of Epidemiology & Population Health and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.
Kathleen E MaloneFred Hutchinson Cancer Research Center, Seattle, WA, USA.
Lene MellemkjaerDanish Cancer Society Research Center, Copenhagen, Denmark.
Rikke LangballeDanish Cancer Society Research Center, Copenhagen, Denmark.
Xiaolin LiangMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Meghan WoodsMemorial Sloan Kettering Cancer Center, New York, NY, USA.
Marc TischkowitzDepartment of Medical Genetics, NIHR Cambridge Biomedical Research Centre, University of Cambridge, Cambridge, UK.
Patrick ConcannonGenetics Institute and Department of Pathology, Immunology and Laboratory Medicine, University of Florida, Gainesville, FL, USA.
Daniel O StramDepartment of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
WECARE Study Collaborative Group
Memorial Sloan Kettering Cancer Center · USCity Of Hope National Medical Center · USDanish Cancer Society · DKUniversity of Toronto · CAFred Hutch Cancer Center · USNew York University · USStanford University · USThe University of Texas MD Anderson Cancer Center · USUniversity of Cambridge · GBUniversity of Florida · USUniversity of Iowa · USUniversity of Southern California · USVanderbilt University Medical Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Douglas Robert Spitz · 2000 to 2026
$70.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
Genome-Wide Association Study of Radiation Exposure and Bilateral Breast CancerR01CA129639 · NCI · SLOAN-KETTERING INST CAN RESEARCH · PI BERNSTEIN, JONINE L. · 2009 to 2013
$15.6M
BREAST CANCER, RADIATION EXPOSURE, AND THE ATM GENEU01CA083178 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BERNSTEIN, JONINE LISA · 1999 to 2003
$9.3M
Interaction of Radiation, BRCA1/2, and Breast CancerR01CA097397 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BERNSTEIN, JONINE LISA · 2002 to 2006
$4.1M
Breast Cancer, Radiation and the ATM-CHEK2 PathwayR01CA114236 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI BERNSTEIN, JONINE L. · 2005 to 2008
$1.8M
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA097397NCI NIH HHS R01 CA114236NCI NIH HHS R01 CA129639NCI NIH HHS U01 CA083178NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

objectiveTo examined the impact of reproductive factors on the relationship between radiation treatment (RT) for a first breast cancer and risk of contralateral breast cancer (CBC).

methodsThe Women's Environmental Cancer and Radiation Epidemiology (WECARE) Study is a multi-center, population-based case-control study where cases are women with asynchronous CBC (N = 1521) and controls are women with unilateral breast cancer (N = 2211). Rate ratios (RR) and 95% confidence intervals (CI) were estimated using conditional logistic regression to assess the independent and joint effects of RT (ever/never and location-specific stray radiation dose to the contralateral breast [0, >0-<1Gy, ≥1Gy]) and reproductive factors (e.g., parity).

resultsNulliparous women treated with RT (≥1Gy dose) were at increased risk of CBC compared with nulliparous women not treated with RT, although this relationship did not reach statistical significance (RR = 1.34, 95% CI 0.87, 2.07). Women treated with RT who had an interval pregnancy (i.e., pregnancy after first diagnosis and before second diagnosis [in cases]/reference date [in controls]) had an increased risk of CBC compared with those who had an interval pregnancy with no RT (RR = 4.60, 95% CI 1.16, 18.28). This was most apparent for women with higher radiation doses to the contralateral breast.

conclusionAmong young female survivors of breast cancer, we found some evidence suggesting that having an interval pregnancy could increase a woman's risk of CBC following RT for a first breast cancer. While sampling variability precludes strong interpretations, these findings suggest a role for pregnancy and hormonal factors in radiation-associated CBC.

Indexed as

AdultAgedBreastBreast NeoplasmsCase-Control StudiesFemaleHumansLogistic ModelsMiddle AgedNeoplasms, Radiation-InducedNeoplasms, Second PrimaryParityPregnancyReproductive Physiological PhenomenaRisk FactorsContralateral breast cancerRadiation treatmentReproductive factorsWECARE Study

Identifiers

PMID32927238
PMCPMC7494790
OpenAlexW3081095386

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.